Riskpilot← Back to searchSign inGet full accessImmune Booster Global AB
ABBankruptOrg 5591965230Retail sale of other food · NACE 4727Est. 20190 employees
Revenue 2023
SEK 0
EBITDA margin
—
0% vs 2022
Equity ratio
88.6%
Financial strength
Net profit 2023
SEK -6K
0% vs 2022
| Revenue | SEK 0 | — |
| EBITDA | SEK -6K | +0% |
| Net profit | SEK -6K | +0% |
| Total assets | SEK 35K | -8% |
| Equity | SEK 31K | -16% |
| Employees | 0 | — |
Legal name
Immune Booster Global AB
Org number
5591965230
Legal form
Aktiebolag
NACE code
4727 · Retail sale of other food
Founded
27 februari 2019
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Import och försäljning av primärt kaffebönor, mald kaffe, te, juice och liknande livsmedel. Fokus kommer vara varor som kaffe men andra livsmedelsvaror kan komma att innefattas när företaget växer. Försäljning av dessa varor kommer primärt att ske till caféer, livsmedelsbutiker samt online på vår webbshop.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenue | 0 | 51 | 13 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −16 | −50 | — | −6 | −6 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −16 | −50 | 0 | −6 | −6 |
| Net financials | — | — | — | — | — |
| Profit before tax | −16 | −50 | 0 | −6 | −6 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −16 | −50 | 0 | −6 | −6 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Total assets | 94 | 46 | 45 | 38 | 35 |
| Equity | 34 | 43 | 44 | 37 | 31 |
| Long-term debt | 60 | 1 | 1 | 1 | 4 |
| Short-term debt | 0 | 2 | 1 | 0 | 0 |
| Total debt | 60 | 3 | 2 | 1 | 4 |
EBITDA margin
-600000.0%
This company
15.8%
Market median
-3797568% vs market
20192023
Equity ratio
88.6%
This company
38.2%
Market median
+132% vs market
20192023
Return on equity
-19.4%
This company
18.4%
Market median
-205% vs market
20192023
Net profit margin
-600000.0%
This company
8.1%
Market median
-7407507% vs market
20192023
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20192023
Debt / equity
0.13×
This company
0.62×
Market median
+79% vs market
20192023
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-02-01 – 2019-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
| Former (2) | ||
| Chairman | 2022 – 2022 | |
| Board of Directors | 2022 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Immune Booster Global AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Christian Pierre Gabriel | Chairman | 0 companies |
| Afram Georges | Chairman | 0 companies |
| Melinda Georges | Board of Directors | 0 companies |
| Birgit Margarete Jeanine Couvelaire-Lejeune | Deputy Board Member | 0 companies |
| Alexander Jacob Geni | Board of Directors | 0 companies |